STATE STREET CORP - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 96 filers reported holding UTAH MED PRODS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$6,117,847
-7.7%
70,896
-0.0%
0.00%
Q2 2023$6,630,499
-2.4%
70,916
-0.7%
0.00%
Q1 2023$6,791,748
-51.9%
71,446
-49.0%
0.00%
Q4 2022$14,119,642
+136.9%
140,050
+101.1%
0.00%
Q3 2022$5,961,000
-1.2%
69,635
-0.5%
0.00%
Q2 2022$6,034,000
-5.2%
70,003
-0.8%
0.00%
Q1 2022$6,363,000
-7.7%
70,584
+2.4%
0.00%
Q4 2021$6,893,000
+9.9%
68,934
+2.4%
0.00%
Q3 2021$6,270,000
+11.2%
67,335
+1.9%
0.00%
Q2 2021$5,636,000
-6.2%
66,053
-4.5%
0.00%
Q1 2021$6,008,000
-8.2%
69,141
-10.6%
0.00%
Q4 2020$6,545,000
+7.8%
77,376
+2.2%
0.00%
Q3 2020$6,071,000
-11.1%
75,746
-1.4%
0.00%
Q2 2020$6,826,000
-4.5%
76,787
+1.3%
0.00%
-100.0%
Q1 2020$7,148,000
-15.0%
75,779
-2.5%
0.00%0.0%
Q4 2019$8,408,000
+18.2%
77,721
+5.0%
0.00%0.0%
Q3 2019$7,113,000
+2.8%
74,005
+2.6%
0.00%0.0%
Q2 2019$6,922,000
+7.6%
72,127
-0.8%
0.00%0.0%
Q1 2019$6,435,000
-19.3%
72,679
-24.0%
0.00%0.0%
Q4 2018$7,970,000
-11.9%
95,617
-0.5%
0.00%0.0%
Q3 2018$9,050,000
-9.9%
96,115
+5.4%
0.00%0.0%
Q2 2018$10,041,000
+14.4%
91,187
+2.7%
0.00%0.0%
Q1 2018$8,775,000
+20.9%
88,758
-0.5%
0.00%0.0%
Q4 2017$7,258,000
+11.2%
89,197
+0.5%
0.00%0.0%
Q3 2017$6,526,000
+13.6%
88,786
+11.8%
0.00%0.0%
Q2 2017$5,746,000
+27.3%
79,382
+9.6%
0.00%
Q1 2017$4,512,000
-15.7%
72,457
-1.6%
0.00%
-100.0%
Q4 2016$5,355,000
+30.9%
73,616
+7.6%
0.00%
Q3 2016$4,091,000
-1.0%
68,412
+4.3%
0.00%
Q2 2016$4,134,000
+11.0%
65,616
+10.3%
0.00%
Q1 2016$3,724,000
+16.3%
59,506
+8.9%
0.00%
Q4 2015$3,201,000
+17.3%
54,651
+7.9%
0.00%
Q3 2015$2,729,000
-5.2%
50,658
+5.0%
0.00%
Q2 2015$2,880,000
+0.5%
48,259
+0.9%
0.00%
Q1 2015$2,867,000
+1.5%
47,837
+1.7%
0.00%
Q4 2014$2,824,000
+26.2%
47,022
+2.6%
0.00%
Q3 2014$2,238,000
-4.3%
45,817
+0.7%
0.00%
Q2 2014$2,338,000
-11.2%
45,516
+0.1%
0.00%
Q1 2014$2,633,000
-37.5%
45,451
-49.8%
0.00%
Q4 2013$4,215,000
+52.8%
90,526
+95.2%
0.00%
Q3 2013$2,759,000
+11.3%
46,365
+1.4%
0.00%
Q2 2013$2,479,00045,7100.00%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2019
NameSharesValueWeighting ↓
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 206,929$10,644,0002.36%
Bares Capital Management 303,667$15,621,0001.28%
Clean Yield Group 9,271$477,0000.24%
Ativo Capital Management LLC 7,072$364,0000.16%
Penobscot Investment Management Company, Inc. 7,400$381,0000.13%
Ancora Advisors LLC 15,955$821,0000.11%
Wallace Capital Management Inc. 9,488$488,0000.10%
Hillsdale Investment Management Inc. 4,400$226,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,300$1,867,0000.05%
CRAWFORD INVESTMENT COUNSEL INC 19,980$1,028,0000.04%
View complete list of UTAH MED PRODS INC shareholders